CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- 4 Planned sale CHIEF OPERATING OFFICER sold 17,000 shares at $26.87 ($456,790)
- 144 Insider Sale of Securities
- SC 13D/A Stake Beneficial Ownership Report
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes CHIEF ACCOUNTING OFFICER gave up 82 shares (to pay taxes)
- 4 Grant or award Director acquired 9,460 shares (grant or award)
- 8-K Event Executive or director change
- 4 Planned sale CHIEF OPERATING OFFICER sold 17,500 shares at $24.99 ($437,325)
- 144 Insider Sale of Securities
- 4 Shares withheld for taxes CHIEF ACCOUNTING OFFICER gave up 3,084 shares (to pay taxes)
- 4 Shares withheld for taxes CHAIRMAN & CEO gave up 11,144 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF OPERATING OFFICER gave up 1,899 shares (to pay taxes)
- 4 Planned sale CHIEF MEDICAL OFFICER sold 60,692 shares at an average $26.12 ($1,584,991)
- 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 3,216 shares (to pay taxes)
- 4 Planned sale CHIEF COMMERCIAL OFFICER sold 68,506 shares at an average $26.12 ($1,789,190)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF OPERATING OFFICER sold 17,500 shares at $26.91 ($470,925)
- 144 Insider Sale of Securities
- 4 Planned sale CHAIRMAN & CEO sold 136,124 shares at an average $25.65 ($3,491,947)
Page 15 of 39 · 778 filings